BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 19896224)

  • 41. Effects of Akt signaling on nuclear reprogramming.
    Nakamura T; Inoue K; Ogawa S; Umehara H; Ogonuki N; Miki H; Kimura T; Ogura A; Nakano T
    Genes Cells; 2008 Dec; 13(12):1269-77. PubMed ID: 19032345
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Can controlled cellular reprogramming be achieved using microRNAs?
    Sun X; Fu X; Han W; Zhao Y; Liu H
    Ageing Res Rev; 2010 Oct; 9(4):475-83. PubMed ID: 20601195
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transplantation tolerance in an age of induced pluripotency.
    Fairchild PJ
    Curr Opin Organ Transplant; 2009 Aug; 14(4):321-5. PubMed ID: 19542888
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatic differentiation of pluripotent stem cells.
    Loya K; Eggenschwiler R; Ko K; Sgodda M; André F; Bleidissel M; Schöler HR; Cantz T
    Biol Chem; 2009 Oct; 390(10):1047-55. PubMed ID: 19642877
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Embryonic stem cells: a great hope for a new era of medicine.
    Tutter AV; Baltus GA; Kadam S
    Curr Opin Drug Discov Devel; 2006 Mar; 9(2):169-75. PubMed ID: 16566287
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oct4-induced pluripotency in adult neural stem cells.
    Kim JB; Sebastiano V; Wu G; Araúzo-Bravo MJ; Sasse P; Gentile L; Ko K; Ruau D; Ehrich M; van den Boom D; Meyer J; Hübner K; Bernemann C; Ortmeier C; Zenke M; Fleischmann BK; Zaehres H; Schöler HR
    Cell; 2009 Feb; 136(3):411-9. PubMed ID: 19203577
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non cell-autonomous reprogramming of adult ocular progenitors: generation of pluripotent stem cells without exogenous transcription factors.
    Balasubramanian S; Babai N; Chaudhuri A; Qiu F; Bhattacharya S; Dave BJ; Parameswaran S; Carson SD; Thoreson WB; Sharp JG; Rao M; Ahmad I
    Stem Cells; 2009 Dec; 27(12):3053-62. PubMed ID: 19859985
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemical biology in stem cell research.
    Choi Y; Nam TG
    Arch Pharm Res; 2012 Feb; 35(2):281-97. PubMed ID: 22370782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular mechanisms involved in self-renewal and pluripotency of embryonic stem cells.
    Liu N; Lu M; Tian X; Han Z
    J Cell Physiol; 2007 May; 211(2):279-86. PubMed ID: 17195167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systems biology approaches to understanding stem cell fate choice.
    Peltier J; Schaffer DV
    IET Syst Biol; 2010 Jan; 4(1):1-11. PubMed ID: 20001088
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induced pluripotent stem cells: current progress and potential for regenerative medicine.
    Amabile G; Meissner A
    Trends Mol Med; 2009 Feb; 15(2):59-68. PubMed ID: 19162546
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proteomic analysis of membrane proteins expressed specifically in pluripotent murine embryonic stem cells.
    Intoh A; Kurisaki A; Yamanaka Y; Hirano H; Fukuda H; Sugino H; Asashima M
    Proteomics; 2009 Jan; 9(1):126-37. PubMed ID: 19053146
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Directed embryonic stem cell differentiation with small molecules.
    Zhu S; Wurdak H; Schultz PG
    Future Med Chem; 2010 Jun; 2(6):965-73. PubMed ID: 21426114
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Somatic cell reprogramming for regenerative medicine: SCNT vs. iPS cells.
    Pan G; Wang T; Yao H; Pei D
    Bioessays; 2012 Jun; 34(6):472-6. PubMed ID: 22419173
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reprogramming adult hematopoietic cells.
    Kaneko S; Otsu M; Nakauchi H
    Curr Opin Hematol; 2010 Jul; 17(4):271-5. PubMed ID: 20571391
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Very small embryonic-like stem cells for regenerative medicine: WO2010039241.
    Taupin P
    Expert Opin Ther Pat; 2010 Aug; 20(8):1103-6. PubMed ID: 20518618
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human stem cell research and regenerative medicine--present and future.
    Volarevic V; Ljujic B; Stojkovic P; Lukic A; Arsenijevic N; Stojkovic M
    Br Med Bull; 2011; 99():155-68. PubMed ID: 21669982
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Application of small molecule compounds inducing differentiation of stem cells].
    Li X; Shan L; Li WL; Zhang SD; Zhang WD
    Yao Xue Xue Bao; 2011 Feb; 46(2):121-6. PubMed ID: 21542280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhancing the efficiency of direct reprogramming of human mesenchymal stem cells into mature neuronal-like cells with the combination of small molecule modulators of chromatin modifying enzymes, SMAD signaling and cyclic adenosine monophosphate levels.
    Alexanian AR; Liu QS; Zhang Z
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1633-8. PubMed ID: 23665234
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advances in cell lineage reprogramming.
    Zhou J; Yue W; Pei X
    Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.